In a look at how physical therapy could help correct the nation's prevalent “opioid-centered” method of pain management, Fierce Healthcare points to a recent study showing that our Virtual Exercise Rehabilitation Assistant (VERA™) telerehab platform “could significantly reduce postsurgical costs.”
The International Congress for Joint Reconstruction has published an article covering the study presented by the Yale University School of Medicine at the AAOS 2019 Annual Meeting showing the effectiveness of our VERA™ telerehab platform in helping total joint arthroplasty, surgeons “save money without sacrificing patient outcomes.“
The Medical Design & Outsourcing news source has published an article focusing on the pair of studies centering about our Virtual Exercise Rehabilitation Assistant (VERA™) telerehab/virtual physical therapy platform presented at the 2019 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
On March 14 and 15, the Duke Clinical Research Institute and Yale New Haven Health will present findings at AAOS 2019 showing groundbreaking results in adult reconstruction knee surgery rehab and practice management/rehabilitation achieved with our Virtual Exercise Rehabilitation Assistant (VERA™) telerehab platform.
OPEN MINDS recently published an article exploring early results from the Duke Clinical Research Institute’s VERITAS study, which shows that our model of virtual physical therapy is as safe and efficient as the traditional style, with the potential to offer major post-surgical cost savings, to boot.
The announcement of positive results from the Duke Clinical Research Institute (DCRI)’s long-anticipated “Virtual Exercise Rehabilitation In-home Therapy: A Research Study (VERITAS)” has been reverberating throughout the media in recent weeks, making headlines in healthcare, technology and business publications.
“There was little difference in pain management between the group that used VERA and the one that used traditional in-person physical therapy,” writes Kelsey Ketchum for Healthcare Business & Technology. “This could be an opportunity to cut down on pain medications after surgery, which is a positive considering the national opioid crisis.”
Reflexion Health CEO Dr. Joe Smith recently walked Orthopedics This Week through the results and milestones of the VERITAS clinical trial — the soon-to-be published study showing that our VERA virtual PT platform is as safe and effective as traditional therapy for TKR patients, while offering the power to sharply reduce post-acute costs, to boot.
Fierce Healthcare’s Paige Minemyer recently covered the groundbreaking findings from the Duke Clinical Research Institute (DCRI) that Reflexion Health’s Virtual Exercise Rehabilitation Assistant (VERA™) “could significantly reduce postsurgical costs” associated with knee replacement surgery, with “an average cost savings of $2,745 per patient treated.”